Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase
1. The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2. Novosys Health, Green Brook, NJ, USA;3. Bristol-Myers Squibb, Lawrenceville, NJ, USA